Popular topics to explore
Anuh Pharma Q3FY26: Revenue at ₹197.18 Cr, Margins Improve
💊 ANUHPHR reported solid Q3FY26 performance with unaudited revenue of ₹19,717.81 lakhs and net profit of ₹1,345.10 lakhs, reflecting improved margins and steady operational execution during the quarter.
💊 Anuh Pharma Secures Key Approval 🌍 ANUHPHR
Anuh Pharma Ltd has been granted a Certificate of Suitability (CEP) from EDQM for Sulfadimethoxine, an important API used in pharmaceutical formulations. Why this is significant 👇 • Enables broader access to highly regulated international…
ANUHPHR . – Bullish Outlook with Upside Target of ₹86
ANUHPHR ., a well-established player in the pharmaceutical sector, is showing signs of bullish momentum backed by both strong fundamentals and positive technical indicators. The company has demonstrated steady revenue growth over the past…
Stock in Focus
DOMS: Net profit at Rs 51.3 cr vs Rs 36.0 cr, Revenue at Rs 458 cr vs Rs 382 cr (YoY) (Positive) Healthcare Global: Net profit at Rs 18 cr vs Rs 13.6 cr, Revenue at Rs 552 cr vs Rs 486 cr (YoY) (Positive) Fortis: Net profit at Rs 193 cr v…
15th Aug 2024 · SEBI-Registered Analyst
Short Term Investing with M.J Research · 15th Aug 2024
Ex Dividend date on 16-08-2024
1. Abirami Financial Services Rs. 2.5 per share 2. Alkali Metals Rs. 1 per share 3. Anuh Pharma Rs. 2.5 per share 4. Apollo Hospitals Rs. 10 per share 5. Astral Rs. 2.25 per share 6. Bata India Rs. 10 per share 7. Bella Casa Fashion Rs. 0.9…
